454 related articles for article (PubMed ID: 37190213)
1. Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz KS; Ott M; Kalmbach S; Steinlein S; Kalla C; Horn H; Ott G; Staiger AM
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190213
[TBL] [Abstract][Full Text] [Related]
2. Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.
Ott G
Br J Haematol; 2017 Sep; 178(6):871-887. PubMed ID: 28748558
[TBL] [Abstract][Full Text] [Related]
3. [Classification of aggressive B-cell lymphomas : News and open questions].
Rosenwald A; Menter T; Dirnhofer S
Pathologie (Heidelb); 2023 May; 44(3):166-172. PubMed ID: 36918411
[TBL] [Abstract][Full Text] [Related]
4. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
5. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas.
Willenbacher E; Willenbacher W; Weger R; Dominik W; Manzl C; Brunner A
Ann Hematol; 2020 Sep; 99(9):2125-2132. PubMed ID: 32613279
[TBL] [Abstract][Full Text] [Related]
6. [The 5th edition of the WHO classification of lymphoid neoplasms-an overview].
Kurz KS; Ott G
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):64-70. PubMed ID: 36239779
[TBL] [Abstract][Full Text] [Related]
7. A large single-institution retrospective analysis of aggressive B-cell lymphomas according to the 2016/2017 WHO classification.
Jesionek-Kupnicka D; Braun M; Robak T; Kuncman W; Kordek R
Adv Clin Exp Med; 2019 Oct; 28(10):1359-1365. PubMed ID: 31518494
[TBL] [Abstract][Full Text] [Related]
8. Mutational landscape of high-grade B-cell lymphoma with
Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N
Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985
[TBL] [Abstract][Full Text] [Related]
9. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
[TBL] [Abstract][Full Text] [Related]
10. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
[TBL] [Abstract][Full Text] [Related]
11. Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data.
Kurz KS; Kalmbach S; Ott M; Staiger AM; Ott G; Horn H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765742
[TBL] [Abstract][Full Text] [Related]
12. High-grade B-Cell lymphoma with
Rogers TS; Gardner JA; Devitt KA
Autops Case Rep; 2019; 9(3):e2019090. PubMed ID: 31440479
[TBL] [Abstract][Full Text] [Related]
13. Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
de Jonge AV; Duetz C; Bruins WSC; Korst CLBM; Rentenaar R; Cosovic M; Eken M; Twickler I; Nijland M; van der Poel MWM; de Heer K; Klerk CPW; Strobbe L; Oosterveld M; Boersma R; Koene HR; Roemer MGM; van Werkhoven E; Chamuleau MED; Mutis T
Blood Adv; 2024 Mar; 8(5):1094-1104. PubMed ID: 38191686
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
15. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry.
Lešková K; Szépe P; Balhárek T; Barthová M; Janáková Ľ; Farkašová A; Plank L
Neoplasma; 2022 Jul; 69(4):957-964. PubMed ID: 35652622
[TBL] [Abstract][Full Text] [Related]
16. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
Grimm KE; O'Malley DP
Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
[TBL] [Abstract][Full Text] [Related]
17. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L;
J Pathol; 2024 Mar; 262(3):255-270. PubMed ID: 38180354
[TBL] [Abstract][Full Text] [Related]
18. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Baptista MJ; Tapia G; Muñoz-Marmol AM; Muncunill J; Garcia O; Montoto S; Gribben JG; Calaminici M; Martinez A; Veloza L; Martínez-Trillos A; Aldamiz T; Menarguez J; Terol MJ; Ferrandez A; Alcoceba M; Briones J; González-Barca E; Climent F; Muntañola A; Moraleda JM; Provencio M; Abrisqueta P; Abella E; Colomo L; García-Ballesteros C; Garcia-Caro M; Sancho JM; Ribera JM; Mate JL; Navarro JT
Histopathology; 2022 Dec; 81(6):826-840. PubMed ID: 36109172
[TBL] [Abstract][Full Text] [Related]
19. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
20. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma.
Cho YA; Hyeon J; Lee H; Cho J; Kim SJ; Kim WS; Ko YH
Hum Pathol; 2021 Jul; 113():9-19. PubMed ID: 33771538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
